Information  X 
Enter a valid email address

Imperial Brands PLC (IMB)

  Print      Mail a friend       Annual reports

Wednesday 10 July, 2019

Imperial Brands PLC

Share buy-back programme

RNS Number : 0518F
Imperial Brands PLC
10 July 2019
 

Imperial Brands PLC

Share buy-back programme


Imperial Brands PLC (the "Company") announced on 8 July 2019 its intention to commence a share buy-back programme (the "Programme") of up to £200 million.  The Company also announces that it has instructed its broker, Barclays Bank PLC, acting through its investment bank ("Barclays") to purchase its shares (acting as principal) for immediate on-sale to the Company up to the value of £200 million in aggregate, commencing from 10 July 2019. 

 

The Company's shareholders generally authorised the Company to purchase up to a maximum of 95,370,000, with this authority granted at the 2019 Annual General Meeting held on 6 February 2019. Pursuant to such authority, the Company intends to purchase shares during the period commencing 10 July 2019 and ending no later than 31 December 2019. The aggregate number of shares acquired by the Company pursuant to the Programme shall not exceed the maximum number of shares which the Company is authorised to purchase pursuant to such general authorities. It is intended that any shares repurchased under the Programme will be cancelled. 

 

The purpose of the Programme is to reduce the capital of Imperial Brands plc. Any purchases of shares by the Company in relation to the Programme will be carried out in accordance with (and subject to the limits prescribed by) the Company's general authority to repurchase shares granted by its shareholders, the Market Abuse Regulation 596/2014, the Commission Delegated Regulation (EU) 2016/1052 and Chapter 12 of the Financial Conduct Authority's Listing Rules.

 

For further information please contact

 

Peter Durman

+44 7970 328 903

Matt Sharff

+44 7964 110 921

James King

+44 7581 052 880

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
POSLIFVEDRIILIA

a d v e r t i s e m e n t